» Articles » PMID: 19099570

Treatments for Irritable Bowel Syndrome: Patients' Attitudes and Acceptability

Overview
Publisher Biomed Central
Date 2008 Dec 23
PMID 19099570
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Irritable Bowel Syndrome, a highly prevalent chronic disorder, places significant burden on the health service and the individual. Symptomatic distress and reduced quality of life are compounded by few efficacious treatments available. As researchers continue to demonstrate the clinical efficacy of alternative therapies, it would be useful to gain a patient-perspective of treatment acceptability and identify patient's attitudes towards those modalities considered not acceptable.

Methods: Six hundred and forty-five participants identified from an earlier IBS-prevalence study received a postal questionnaire to evaluate preferences and acceptability of nine forms of treatment. Proportions accepting each form of treatment were calculated and thematic analysis of qualitative data undertaken.

Results: A total of 256 (39.7%) of 645 potential respondents completed the questionnaire (mean age 55.9 years, 73% female). Tablets were most acceptable (84%), followed by lifestyle changes (diet (82%), yoga (77%)). Acupuncture (59%) and suppositories (57%) were less acceptable. When explaining lack of acceptability, patient views fell into four broad categories: dislike treatment modality, do not perceive benefit, general barriers and insufficient knowledge. Scepticism, lack of scientific rationale and fear of CAM were mentioned, although others expressed a dislike of conventional medical treatments. Past experiences, age and health concerns, and need for proof of efficacy were reported.

Conclusion: Most patients were willing to accept various forms of treatment. However, the reservations expressed by this patient-population must be recognised with particular focus directed towards allaying fears and misconceptions, seeking further evidence base for certain therapies and incorporating physician support and advice.

Citing Articles

Nerva, a mobile application of gut-directed hypnotherapy for irritable bowel syndrome: User characteristics, patterns of use, and predictors of persistence.

Simicich L, Muniz V, Scheffrahn K, Elkins G Digit Health. 2024; 10:20552076241263257.

PMID: 38882251 PMC: 11179457. DOI: 10.1177/20552076241263257.


The effect of eye movement desensitization and reprocessing (EMDR) on abdominal pain in patients with irritable bowel syndrome (IBS): a study protocol for a randomized controlled trial (EMDR4IBS).

Wertheim B, Aarts E, de Roos C, van Rood Y Trials. 2023; 24(1):785.

PMID: 38049872 PMC: 10696837. DOI: 10.1186/s13063-023-07784-1.


Gastroenterologist and Patient Attitudes Toward Yoga as a Therapy for Irritable Bowel Syndrome: An Application of the Theory of Planned Behaviour.

DSilva A, Marshall D, Vallance J, Nasser Y, Taylor L, Lazarescu A J Can Assoc Gastroenterol. 2023; 6(1):17-25.

PMID: 36789144 PMC: 9915057. DOI: 10.1093/jcag/gwac028.


Predictors of Symptom-Specific Treatment Response to Dietary Interventions in Irritable Bowel Syndrome.

Colomier E, Van Oudenhove L, Tack J, Bohn L, Bennet S, Nybacka S Nutrients. 2022; 14(2).

PMID: 35057578 PMC: 8780869. DOI: 10.3390/nu14020397.


Effectiveness of Non-Pharmacological Interventions for Irritable Bowel Syndrome: A Systematic Review.

Amsallem F, Sanchez S, Armoiry X, Mion F Evid Based Complement Alternat Med. 2021; 2021:4404185.

PMID: 34790245 PMC: 8592737. DOI: 10.1155/2021/4404185.


References
1.
Ernst E . Complementary medicine: implications for informed consent in general practice. Br J Gen Pract. 2004; 54(499):82-3. PMC: 1314797. View

2.
Hussain Z, Quigley E . Systematic review: Complementary and alternative medicine in the irritable bowel syndrome. Aliment Pharmacol Ther. 2006; 23(4):465-71. DOI: 10.1111/j.1365-2036.2006.02776.x. View

3.
Shi J, Tong Y, Shen J, Li H . Effectiveness and safety of herbal medicines in the treatment of irritable bowel syndrome: a systematic review. World J Gastroenterol. 2008; 14(3):454-62. PMC: 2679136. DOI: 10.3748/wjg.14.454. View

4.
van den Brink-Muinen A, Rijken P . Does trust in health care influence the use of complementary and alternative medicine by chronically ill people?. BMC Public Health. 2006; 6:188. PMC: 1544335. DOI: 10.1186/1471-2458-6-188. View

5.
Cash B, Sullivan S, Barghout V . Total costs of IBS: employer and managed care perspective. Am J Manag Care. 2005; 11(1 Suppl):S7-16. View